• Home
  • About
    • Author Guidelines
    • Editorial Board
  • Contact
  • Issue Archive
    • 2017
    • 2016
    • 2015
  • Special Issues
    • Supplements
    • Conquering the Cancer Care Continuum
      • Series Two
      • Series Three
    • Faculty Perspectives
    • Immuno-oncology
    • Mechanism of Action/Pathway Profiles
Personalized Medicine in Oncology
Subscribe
Subscribe to Personalized Medicine in Oncology

To sign up for our e-mail newsletter or print publications, fill out the information below and click Subscribe.

Country
Menu
  • PMO Interview with the Innovator Series
  • Conference Correspondent
    • ASCO 2020
    • ESMO 2018
    • ESMO 2016
  • Web Exclusives
    • FDA Approvals, News & Updates
    • Press Releases
  • Continuing Education
  • Videos
    • 2018 AONN Midyear
    • 2018 ASCO Insights
    • The Biomarker
  • PMO Interview with the Innovator Series
  • Conference Correspondent
    • ASCO 2020
    • ESMO 2018
    • ESMO 2016
  • Web Exclusives
    • FDA Approvals, News & Updates
    • Press Releases
  • Continuing Education
  • Videos
    • 2018 AONN Midyear
    • 2018 ASCO Insights
    • The Biomarker
  • Home
  • About
    • Author Guidelines
    • Editorial Board
  • Contact
  • Issue Archive
    • 2017
    • 2016
    • 2015
  • Special Issues
    • Supplements
    • Conquering the Cancer Care Continuum
      • Series Two
      • Series Three
    • Faculty Perspectives
    • Immuno-oncology
    • Mechanism of Action/Pathway Profiles

Immuno-oncology

2016
January 2016
Vol. 3, No. 1
  • View this Issue
2015
November 2015
Vol. 2, No. 6
  • View this Issue
September 2015
Vol. 2, No. 5
  • View this Issue
July 2015
Vol. 2, No. 4
  • View this Issue
May 2015
Vol. 2, No. 3
  • View this Issue
March 2015
Vol. 2, No. 2
  • View this Issue
January 2015
Vol. 2, No. 1
  • View this Issue
2014
November 2014
Part 4
  • View this Issue
September 2014
Part 3
  • View this Issue
June 2014
Part 2
  • View this Issue
April 2014
Part 1
  • View this Issue
In the News
    May 19, 2016

    Two-pronged attack on chemotherapy-resistant leukemia cells

    May 18, 2016

    An Early Look at Research From the 2016 ASCO Annual Meeting

    May 18, 2016

    Drug against breast cancer is also highly potent against a frequent form of leukaemia

    May 17, 2016

    Improving natural killer cancer therapy: Study

linkedin
Connect with us

Sign me up!

Copyright 2021. Green Hill Healthcare Communications, LLC. All Rights Reserved. Privacy Policy. Sitemap.

By continuing to browse the site you are agreeing to our use of cookies.